Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMCU6RF)

Drug Name

ISIS 156452 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting IRAK4 messenger RNA (IRAK4 mRNA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ISIS 156453	DMQ9018	Discovery agent	N.A.	Investigative	[1]
N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide	DM0CWPX	Discovery agent	N.A.	Investigative	[2]
ISIS 156451	DMPH2W7	Discovery agent	N.A.	Investigative	[1]
ISIS 156473	DMDFUS8	Discovery agent	N.A.	Investigative	[1]
ISIS 156449	DMPB3FH	Discovery agent	N.A.	Investigative	[1]
ISIS 156474	DMCXP9T	Discovery agent	N.A.	Investigative	[1]
ISIS 156475	DMNB4UJ	Discovery agent	N.A.	Investigative	[1]
N-(1H-benzo[d]imidazol-2-yl)-3-cyanobenzamide	DM054NF	Discovery agent	N.A.	Investigative	[2]
ISIS 156472	DM3U0Z6	Discovery agent	N.A.	Investigative	[1]
ISIS 156471	DMM9ARP	Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	US patent application no. 6,692,959, Antisense modulation of IL-1 receptor-associated kinase-4 expression.
2	Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2842-5.